Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bayer to investigate Kogenate in hemophilia patients
Bayer is hoping that the new long-acting product will change the existing treatment structure for the disease, because it may result weekly, or even less frequent, injections. Currently,
Bayer is hoping that the new long-acting product will change the existing treatment structure for the disease, because it may result weekly, or even less frequent, injections. Currently,
Conforma plans to market Sumitomo’s amrubicin in North America and Europe, with phase II trials scheduled for early 2006. Amrubicin was developed as a treatment for lung cancer,
The University plans to conduct basic, translational and clinical studies using Panzem NCD with a range of chemotherapeutic agents to determine the effect of Panzem, or 2ME2, on
The program consisted of two randomized, placebo-controlled clinical studies that were carried out in moderately depressed patients. One study, which was conducted in 248 depressed patients, demonstrated that
The company said the phase III segment is a randomized study that will compare 200mg daily of KRX-101 versus placebo in 1,000 patients with persistent microalbuminuria. The phase
The patent, which is entitled “AB42 Lowering Agents”, was licensed to Myriad from Rochester, Minnesota-based Mayo Clinic. Amyloid beta 42 is a neurotoxic peptide, which Myriad claims is
The results indicate that treatment with Actos lowered triglycerides, increased HDL-C or “good” cholesterol, and improved LDL-C or “bad” cholesterol particle concentration and particle size. Diabetic dyslipidemia is
The randomized single-dose study was designed to evaluate the pharmacokinetics of sumatriptan, a drug used to treat migraines, at three injection sites in 24 healthy adult male and
The firm said it will use the proceeds from the financing for its general corporate purposes, including the commercialization of its pain relief medicine tramadol in Europe. Hercules
Respiratory syncytial virus (RSV) is a major threat to the very young, the elderly and the immuno-compromised and with no other effective treatment available represents a major unmet